Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo

Clinical trial NCT00824356 · COMPLETED

Trial details

NCT number: NCT00824356
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2008-06-01
Primary completion: 2008-08-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.